The Danaher Bioprocessing Summit highlighted that future biomanufacturing success hinges on increased productivity and process intelligence, rather than just capacity expansion. Key themes included AI-driven development, continuous bioprocessing, and digitalization for personalized medicine manufacturing. This is crucial for developers and tech professionals in the biotech sector, indicating a shift towards data-driven, automated, and collaborative approaches to accelerate therapeutic development and patient delivery.
Read the full article at Genetic Engineering News
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.





